Quantcast

Pharma

Pharma
Pharma

New 'Reactionware' 3D Printing System Spits Out Pharmaceuticals On-Demand

The door is open for making drugs on-site in doctors' offices, or even in space.
Michael Byrne
1.19.18
WEED
WEED

Big Pharma Wants a Monopoly On One of Weed's Key Medicinal Compounds

Corporate lobbyists in more than 20 states are currently pushing to make sure the pharmaceutical industry has the only legal supply of CBD.
David Bienenstock
6.13.17
Pharma
Pharma

To Solve Opioid Addiction, We Still Need to Solve Pain

We know a whole lot about painkillers, but not much about pain itself.
Michael Byrne
3.10.17
Drugs
Drugs

A Drug Meant for Alzheimer’s Treatment Regrows Human Teeth

The drug blocks an enzyme and allows a cavity to heal.
Meredith Rutland Bauer
1.10.17
Drugs
Drugs

New Morphine Alternative Kills Pain Without the OD Risk

Early indications are that it's not addictive either, say researchers.
Michael Byrne
8.17.16
HEALTH
HEALTH

Why Antibiotics Cause Diarrhea

A new study shows how antibiotics add nutrients to the gut, feeding pathogens.
Michael Byrne
6.15.16
Drugs
Drugs

The Chemistry of Ketamine and Depression Isn't What It Seems

Ketamine seems to be a quick, effective treatment for depression, but researchers are only now figuring out why.
Michael Byrne
5.4.16
Twitter
Twitter

Looks Like Martin Shkreli's Twitter Got Hacked

Everyone’s favorite twerp Martin Shkreli has been hacked—at least on Twitter.
Rachel Pick
12.20.15
News
News

This Is Why the Feds Arrested Martin Shkreli

Long before he started drawing public rage for his drug price hike, Shkreli ran a couple of hedge funds.
Kaleigh Rogers and Rachel Pick
12.17.15
video
video

See-Through Zebrafish Offer a Window Into the Chilling Creep of Meningitis

A uniquely unpleasant way to go.
Michael Byrne
10.1.15
Martin Shkreli
Martin Shkreli

A Pill Doesn't Have to Cost $750 To Be Outrageous and Exploitative

Turing is just a symptom of much deeper pharmaceutical woes.
Michael Byrne
9.27.15
mental health
mental health

Treating the Elusive, Disabling ‘Flatness’ of Schizophrenia

A new drug on track for FDA approval offers hope.
Michael Byrne
9.2.15